SPYRE THERAPEUTICS INC (SYRE) Stock Income Statement
NASDAQ:SYRE • US00773J2024
Current stock price
69.67 USD
+0.43 (+0.62%)
At close:
69.67 USD
0 (0%)
After Hours:
| TTM (2025-9-30) | 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 886.00K | 2.33M | |||
| Operating Expenses | 223.75M | 219.56M | 208.57M | 118.50M | 87.11M | |||
| Research and Development | N/A | 171.65M | 162.79M | 84.05M | 58.58M | |||
| Selling, General, and Administrative Expenses | 46.51M | 47.91M | 45.78M | 34.45M | 28.53M | |||
| Operating Income | -223.75M | -219.56M | -208.57M | -117.61M | -84.78M | |||
| Interest Income/Expense | N/A | 24.89M | 21.31M | 25.13M | 840.00K | |||
| Other Income/Expense | 46.81M | 29.46M | -20.71M | -121.65M | -10.00K | |||
| Non Recurring Items | N/A | 10.00M | 0.00 | -124.69M | N/A | |||
| Income Before Taxes | -148.80M | -155.22M | -207.97M | -338.82M | -83.95M | |||
| Income Tax | -14.00K | -15.00K | 51.00K | -26.00K | -140.00K | |||
| Net Income | -148.79M | -155.20M | -208.02M | -338.79M | -83.82M | |||
| EBITDA | N/A | N/A | N/A | -116.87M | -83.21M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.56 | -2.42 | -4.42 | -49.12 | -24.86 | |||
| Non GAAP EPS | -2.33 | -2.22 | -4.23 | -59.89 | -25.25 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | -38238.15% | -3597.42% | |||
| Operating Profit Margin | N/A | N/A | N/A | -13274.49% | -3638.63% | |||
All data in USD